Genome Editing using CRISPR/Cas9

Date Friday, December 07, 2018, 09:00 - 17:00
Location Nielsine Nielsen auditorium, Mærsk Tower, Panum Instituttet
Organizers The Danish Society for Biochemistry and Molecular Biology, IDA Bioteknologi and Danish Biotechnological Society

CRISPR based genome editing technologies are revolutionizing academia, life science and are expected to found the basis for next generation gene therapies. This years mini-symposium will focus on the latest developments in the use of CRISPR/Cas9, repurposed Cas9 based technologies and their use in whole animal and translational research. The conference will include sessions on use of CRISPR/Cas9 based applications in:

  • Drug screening
  • Animal models
  • Therapeutics
  • Future tools and directions 

Confirmed speakers:

  • Jacob Corn, Berkeley, USA/ETH in Zurich, Ch
  • Patrick Hsu, The Salk Institute, USA
  • Katherine Pawelczak , NERx Biosciences, Inc, USA
  • Marie Christine Birling, Phenomin ICS, Strasbourg, Fr 
  • Vincenzo DiDonato, ZeClinics, Es
  • Thomas Tiilmark Eriksen, Lundbeck A/S, Dk
  • Massimo Squatrito, cnio, Es
  • Ed Ryan, Welcome Trust Sanger Institute, Cambridge, GBR
  • Carol Elvira, ThermoFisher, USA
  • Gurpreet Balrey, Merckgroup, UK

Registration is required for participation and limited to 100 participants

Registration is open from November 5th, through the following link:


  • Eric P. Bennett (
  • Morten Frödin (
  • Cord. H. Brakebusch (